Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 4/2002

01-08-2002 | Commentary

ICU Cornerstone: Changing our view of blood transfusions

Authors: Warren L Lee, Gregory P Downey

Published in: Critical Care | Issue 4/2002

Login to get access

Abstract

Blood transfusions are commonly administered to critically ill patients, but deciding when to transfuse a particular patient is often difficult and necessitates careful consideration of both the potential benefits and risks. This commentary briefly discusses some of the considerations both for and against blood transfusion in the setting of critical illness and reviews a landmark clinical trial in this area. Finally, we reflect on the changes in attitudes towards the transfusion of blood and blood products that have taken place over the last 20 years.
Literature
1.
2.
Czer LSC, Shoemaker WC: Optimal hematocrit value in critically ill postoperative patients. Surg Gynecol Obstet 1978, 147: 363-368.PubMed
3.
Corwin HL, Parsonnet KC, Gettinger A: RBC transfusion in the ICU – is there a reason? Chest 1995, 108: 767-771.CrossRefPubMed
4.
Russell JA, Phang PT: The oxygen delivery/consumption controversy–approaches to management of the critically ill. Am J Respir Crit Care Med 1994, 149: 533-537.CrossRefPubMed
5.
Hayes MA, Timmins AC, Yau EHS, Palazzo M, Hinds CJ, Watson D: Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994, 330: 1717-1722. 10.1056/NEJM199406163302404CrossRefPubMed
6.
Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, Fumagalli R, for the SvO2 Collaborative Group: A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995, 333: 1025-1032. 10.1056/NEJM199510193331601CrossRefPubMed
7.
Lorente JA, Landin L, De Pablo R, Renes E, Rodriguez-Diaz R, Liste D: Effects of blood transfusion on oxygen transport variables in severe sepsis. Crit Care Med 1993, 21: 1312-1318.CrossRefPubMed
8.
Dietrich KA, Conrad SA, Hebert CA, Levy GL, Romero MD: Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients. Crit Care Med 1990, 18: 940-944.CrossRefPubMed
9.
Jenson LS, Anderson AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G: Postoperative infection and natural killer cell function following transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992, 79: 513-516.CrossRef
10.
Marik PE, Sibbald WJ: Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA 1993, 269: 3024-3029. 10.1001/jama.269.23.3024CrossRefPubMed
11.
Hébert PC, Wells G, Martin C, Tweeddale M, Marshall J, Blajch-man M, Pagliarello G, Schweitzer I, Calder L: A Canadian survey of transfusion practices in critically ill patients. Crit Care Med 1998, 26: 482-487. 10.1097/00003246-199803000-00019CrossRefPubMed
12.
Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E, and the Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999, 340: 409-417. 10.1056/NEJM199902113400601CrossRefPubMed
13.
McCrossan L, Masterson G: Blood transfusion in critical illness. Br J Anaesth 2002, 88: 6-9. 10.1093/bja/88.1.6CrossRefPubMed
14.
Hébert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, Tweeddale M, Pagliarello G, Schweitzer I, and the Transfusion Requirements in Critical Care Investigators for the Canadian Critical Care Trials Group: Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001, 29: 227-234. 10.1097/00003246-200102000-00001CrossRefPubMed
15.
Dorozynski A: Tainted blood affair threatens French Government. Br Med J 1992, 14: 1177.
16.
Watts J: Japanese official found guilty in HIV-blood trial. Lancet 2001, 358: 1166. 10.1016/S0140-6736(01)06317-6CrossRefPubMed
17.
Capen K: Informed consent and blood transfusions: What does Krever's interim report mean to doctors? CMAJ 1995, 152: 1663-1665.PubMedCentralPubMed
18.
Mann R, Heimbach DM, Engrav LH, Foy H: Changes in transfusion practices in burn patients. J Trauma 1994, 37: 220-222.CrossRefPubMed
19.
Farion KJ, McLellan BA, Boulanger BR, Szalai JP: Changes in red cell transfusion practice among adult trauma victims. J Trauma 1998, 44: 583-587.CrossRefPubMed
20.
CDC: Possible transfusion-associated acquired immune deficiency syndrome (AIDS) – California. MMWR Morb Mortal Wkly Rep 2000, 31: 652-654.
Metadata
Title
ICU Cornerstone: Changing our view of blood transfusions
Authors
Warren L Lee
Gregory P Downey
Publication date
01-08-2002
Publisher
BioMed Central
Published in
Critical Care / Issue 4/2002
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc1512

Other articles of this Issue 4/2002

Critical Care 4/2002 Go to the issue

Commentary

Looking beyond 28-day all-cause mortality

Book report

Pharmacology of the critically ill

Review

Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection

Review

Bench-to-bedside review: A possible resolution of the glucose paradox of cerebral ischemia

Review

Statistics review 4: Sample size calculations

Commentary

The International Sepsis Forum's controversies in sepsis: how will sepsis be treated in 2051?